Administrative Core
Administrative Core
批准号:
8325194
负责人:
Mark Larche
金额:
$11.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-09 至 2013-03-31
关键词:
AddressAllergensAsthmaBloodBlood specimenBone MarrowBronchoalveolar LavageCellsClinicalDiseaseEpitopesFelis catusFrequenciesGoalsHypersensitivityImmunotherapyInterventionLungMHC Class II GenesMemoryPathogenesisPeptidesPhase II Clinical TrialsPhenotypeProductionPublic HealthReagentRegulatory T-LymphocyteResearchResearch InfrastructureResearch Project GrantsSamplingSiteT-LymphocyteUnited States National Institutes of HealthValidationchemokine receptorcytokineimprovedin vivo Modelnovelnovel strategiespre-clinicalprogramsprospectiveresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall long-term objective of the Administrative Core will be to provide scientific direction & oversight, project management and fiscal & administrative infrastructure to support all of the Projects and Cores within the Allergen Epitope Research and Validation Center. The goal of the Administrative Core is to optimally facilitate the scientific objectives and goals of the Center. The scientific objectives and goals of the Center are to use in vivo models (clinical and pre-clinical) to identify, enrich and characterize allergen-specific T cells in order to understand how their frequency and functional phenotype changes in response to an allergen-specific intervention. In Project 1, blood samples from two Phase II clinical trial of peptide immunotherapy (one historic and one prospective) will be subjected to allergen-specific enrichment of T cells
using novel MHC Class II tetramer reagents. Tetramer+ T cells will be characterized for frequency, chemokine receptor expressoin, memory phenotype, cytokine production profiles and regulatory T cell frequency. In Project 2, blood, bone marrow and bronchoalveolar lavage samples will be obtained before and after segmental lung allergen challenge with cat allergen extract. Fel d 1 tetramers will be emioyed to
enrich allergen-specific T cells from each compartment and these cells will be characterized as above.The Administrative Core will support these objectives through the following Specific Aims; Aim 1: to provide scientific direction, guidance and strategy for the Center through interaction between the Center Management Committee (CMC), the NIH Program Officers and the Scientific Advisory Panel (SAP), Aim 2:
to provide (a) project management, (b) coordination of activities/information between projects and sites (3) general administrative support to the Center, Aim 3: to provide fiscal management within the Center (between the three sites) and between the Center and the NIH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
-
批准号:8822807
-
项目类别:
-
资助金额:$123.97万
-
财政年份:2012
-
负责人:Mark Larche
-
依托单位:
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
-
批准号:8651874
-
项目类别:
-
资助金额:$129.26万
-
财政年份:2012
-
负责人:Mark Larche
-
依托单位:
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
-
批准号:8453235
-
项目类别:
-
资助金额:$124.82万
-
财政年份:2012
-
负责人:Mark Larche
-
依托单位:
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
-
批准号:8325192
-
项目类别:
-
资助金额:$67.89万
-
财政年份:2012
-
负责人:Mark Larche
-
依托单位:
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
-
批准号:8305844
-
项目类别:
-
资助金额:$133.09万
-
财政年份:2012
-
负责人:Mark Larche
-
依托单位:
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
-
批准号:8453237
-
项目类别:
-
资助金额:$64.68万
-
财政年份:--
-
负责人:Mark Larche
-
依托单位:
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
-
批准号:9037572
-
项目类别:
-
资助金额:$66.59万
-
财政年份:--
-
负责人:Mark Larche
-
依托单位:
Administrative Core
-
批准号:8651877
-
项目类别:
-
资助金额:$11.13万
-
财政年份:--
-
负责人:Mark Larche
-
依托单位:
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
-
批准号:8651875
-
项目类别:
-
资助金额:$66.91万
-
财政年份:--
-
负责人:Mark Larche
-
依托单位:
Administrative Core
-
批准号:8453239
-
项目类别:
-
资助金额:$10.46万
-
财政年份:--
-
负责人:Mark Larche
-
依托单位:
海外基金